RJ-026

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameRJ-026
Drug Alias NameRJ026RJ-026
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLung Diseases, Interstitial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Rui Jin Hospital
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLung Diseases, Interstitial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A